Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · February 03, 2024

Outcomes of Treatment With Anifrolumab in Patients With Refractory Cutaneous Lupus Erythematosus

International Journal of Dermatology


Additional Info

International Journal of Dermatology
Refractory cutaneous lupus erythematosus successfully treated with anifrolumab: a case series
Int. J. Dermatol 2024 Jan 10;[EPub Ahead of Print], D Martín-Torregrosa, M Mansilla-Polo, MA Lasheras-Pérez, R Botella-Estrada, I Torres-Navarro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading